Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Cardiovascular Disease in Women, Part 2: The Therapeutic Spectrum
The Female Patient, 07/08/09
McNeal CJ et al. - Failure to identify and modify known CVD risk factors early in life misses an important opportunity to prevent the progression of atherosclerosis to symptomatic disease (ie, angina or MI). Prevention of CVD is a priority in women and should be accomplished through lifestyle changes; application of treatment guidelines for hypertension, hyperlipidemia, and DM; and appropriate use of aspirin. With better clinician and patient education and further research to clarify gender differences, there should be a significant decline in CVD morbidity and mortality among female patients.
Related Articles
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09
Relevance Score: 71%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 70%
Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden
Rheumatology, 10/30/09
Relevance Score: 70%
Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09
Relevance Score: 69%
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the Nurses Health Study
Arthritis Care and Research, 10/01/09
Relevance Score: 69%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
British Medical Journal, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


